Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 22, 2025, to report its financial results for the fiscal quarter ended September 27, 2025. The key information is contained within the press release furnished as Exhibit 99.1, which provides details on the company's performance during the quarter. Investors should review this press release for specific financial metrics, operational updates, and forward-looking statements. While the 8-K itself is a notification filing, the accompanying press release (Exhibit 99.1) is the primary source of detailed financial information. This includes earnings per share, revenue figures, and potentially commentary on segment performance and guidance for future periods. The filing clarifies that the information is furnished and not deemed 'filed' for certain legal purposes, a standard disclosure for earnings releases included in 8-Ks.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended September 27, 2025.
- 2The official announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The 8-K was filed on October 22, 2025.
- 4Investors are directed to the furnished press release for comprehensive financial details.
- 5The filing includes standard disclaimers regarding the 'furnished' nature of the information, distinguishing it from 'filed' information under Section 18 of the Exchange Act.